Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals

1. Ramos, J.T.
2. De José, M.I.
3. Dueñas, J.
4. Fortuny, C.
5. González-Montero, R.
6. Mellado, M.J.
7. Mur, A.
8. Navarro, M.
9. Otero, C.
10. Pocheville, I.
11. Muñoz-Fernández, M.A.
12. Cabrero, E.